BCWM
ONC

Bartlett & Co Wealth Management’s BeOne Medicines Ltd ONC Stock Holding History

Bartlett & Co Wealth Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4
Closed -$968 – 1290
2025
Q2 		$968 Buy
+4
New +$981 ﹤0.01% 1147

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bartlett & Co Wealth Management's ONC Position: Q3 2025 in Review

Bartlett & Co Wealth Management sold out of BeOne Medicines Ltd (ONC) in Q3 2025, closing a stake of 4 shares — an estimated $968 sold.

Bartlett & Co Wealth Management first reported a position in ONC in Q2 2025 and held it in 1 quarter. The position peaked at $968 in Q2 2025. 265 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

  • Bartlett & Co Wealth Management reported no remaining BeOne Medicines Ltd position as of Q3 2025 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 4 BeOne Medicines Ltd shares in Q3 2025, an estimated $968.
  • Bartlett & Co Wealth Management first reported a position in BeOne Medicines Ltd in Q2 2025 and held it in 1 quarter.
  • Bartlett & Co Wealth Management's BeOne Medicines Ltd position peaked at $968 in Q2 2025.
  • 265 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on Bartlett & Co Wealth Management's 13F filing for Q3 2025, filed 9 Oct 2025.